<DOC>
	<DOCNO>NCT02526875</DOCNO>
	<brief_summary>To Evaluate Efficacy Timing Administration Telmisartan/S-Amlodipine ( Telminuvo®Tab . 40/2.5mg ) 24-hour BP Control Hypertensive Patients Inadequately Controlled Telmisartan Monotherapy</brief_summary>
	<brief_title>Efficacy Telmisartan/S-Amlodipine 24-hour BP Control Hypertensive Patients Inadequately Controlled</brief_title>
	<detailed_description>A Multicenter , Prospective , Randomized , Open-label , Phase 4 Trial Designed Evaluate Efficacy Timing Administration Telmisartan/S-Amlodipine ( Telminuvo®Tab . 40/2.5mg ) 24-hour BP Control Hypertensive Patients Inadequately Controlled Telmisartan Monotherapy</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . More 20 year hypertension patient 2 . Hypertension satisfy Clinic blood pressure measure time screen TreatmentNaive : Clinic Mean sit diastolic blood pressure ≥ 100mmHg . TreatmentExperienced : Clinic Mean sit diastolic blood pressure ≥ 90mmHg . 3 . Hypertension satisfy Clinic blood pressure measure time randomization Clinic Mean sit diastolic blood pressure ≥ 90mmHg 4 . Patient decide participate sign informed consent form willingly 1 . Clinic Mean sit systolic blood pressure ≥ 180mmHg Clinic Mean sit diastolic blood pressure ≥ 115mmHg time Screening Randomization 2 . As night worker sleep day whose work hour include 00:00 04:00 3 . Secondary Hypertension 4 . Severe heart disease ( Heart failure ; New York Heart Association ( NYHA ) class 3 , 4 ) recent unstable angina myocardial infarction valvular heart disease arrhythmia require treatment within past 3 month 5 . Severe cerebrovascular disorder cerebral infarction , cerebral hemorrhage within 6 month 6. type 1 diabetes mellitus Uncontrolled type 2 diabetes mellitus ( HbA1c &gt; 8.0 % ) 7 . Severe malignant retinopathy 8 . Abnormal laboratory test result Aspartate aminotransferase/Alanine aminotransferase &gt; Upper normal limit X 2 Serum creatinine &gt; Upper normal limit X 2 9 . Acute chronic inflammatory status require treatment 10 . Need antihypertensive drug trial 11 . Need prohibited medication specify protocol 12 . A history angioedema ACE inhibitor angiotensinⅡ receptor blocker 13 . Severe hypersensitivity amlodipine telmisartan 14 . History drug alcohol abuse within 6 month 15 . Surgical medical condition History major gastrointestinal surgery History active inflammatory bowel syndrome within 12 month Abnormal pancreatic function Gastrointestinal/rectal bleed Urinary tract obstruction 16 . Administration Investigational Product within 30 day 17 . Pregnant , breastfeed childbearing age n't use adequate contraception 18 . History malignant tumor within 5 year ( include leukemia lymphoma ) 19 . Another clinical condition investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>hypertension , Telmisartan/S-Amlodipine</keyword>
</DOC>